Multiple sclerosis progression: time for a new mechanism-driven framework

Tanja Kuhlmann(University Hospital Münster), Emmaunelle Waubant, Ellen M. Mowry(Johns Hopkins University), Ari Green(University of California, San Francisco), Marcia Finlayson(Queen's University), María Trojano(University of Bari Aldo Moro), Daniel S. Reich(National Institutes of Health), Helen Tremlett(St. Michael's Hospital), Amber Salter(Salter School), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Timothy Coetzee(National Multiple Sclerosis Society), Anneke van der Walt(The Alfred Hospital), Gıancarlo Comı(Casa di Cura Columbus), Kerstin Hellwig(St. Josef-Hospital), Mar Tintoré(Vall d'Hebron Hospital Universitari), Maria Pia Amato(University of Florence), Jorge Correale(Consejo Nacional de Investigaciones Científicas y Técnicas), Jeffrey A. Cohen(Dartmouth Health), Tanuja Chitnis(Brigham and Women's Hospital), Maria Pia Sormani(University of Genoa), Jennifer Graves(University of California San Diego), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Alan J. Thompson(Queen Mary University of London), Myla Goldman(Virginia Commonwealth University), Tobias Derfuß(University of Basel), Brenda Banwell(Johns Hopkins University), V. Wee Yong(University of Calgary), Ruth Ann Marrie(University of Manitoba), Daphne Kos(KU Leuven), Marcello Moccia(Anna Needs Neuroblastoma Answers), Aaron Miller, Jeremy Chataway(National Institute for Health and Care Research), Sandra Vukusic(Université Claude Bernard Lyon 1), Jiwon Oh(St. Michael's Hospital)
The Lancet Neurology
November 18, 2022
Cited by 624


Related Papers